menu
Presently, around 8 companies worldwide have taken initiatives to develop gene-editing therapies and technologies
Presently, around 8 companies worldwide have taken initiatives to develop gene-editing therapies and technologies
The ability of gene editing solutions to directly target and modify genomic sequences has greatly expedited the progress of gene editing therapies into clinical stages.

The main focus of ZFNs, TALENs and meganucleases based therapeutics is on infectious diseases and oncological disorders; however, several product candidates against certain hematological disorders, genetic disorders and neurological disorders are being evaluated in discovery and preclinical stages of development. Over time, several industry and non-industry players have also been validating the therapeutic applications of these technologies. The future opportunity within the gene editing market has been segmented across [A] type of payment (upfront payment and milestone payment) and [B] geography (North America, Europe, and Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

 

 

To order this 150+ page report, which features 100+ figures and 5+ tables, please visit

https://www.rootsanalysis.com/reports/gene-editing-market.html

 

 

Key companies covered in the report

§  Allogene Therapeutics

§  bluebird bio

§  Cellectis

§  Cytovia Therapeutics

§  Iovance Biotherapeutics

§  Precision Biosciences

§  Sangamo Therapeutics

 

 

Table of Contents

 

1. Preface

 

2. Executive Summary

 

3. Introduction

 

4. ZFNS, TALENS AND MEGANUCLEASES based therapeutics: Market Landscape

 

5. Company Profiles

 

6. Clinical Trial Analysis

 

7. Publication Analysis

 

8. Academic Grants Analysis

 

9. Partnerships and Collaborations

 

10. Funding and Investment Analysis

 

11. Patent Analysis

 

12. Key Insights on KOLs

 

13. Case Study: CRISPR / CAS based therapeutics

 

14. Market Sizing and Opportunity Analysis

 

15. Appendix 1: List of Figures and Tables

 

16. Appendix 2: List of Companies and Organizations

 

 

To request sample pages, please visit

https://www.rootsanalysis.com/reports/gene-editing-market/request-sample.html

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/